Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial

Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record for a Taiwan-based trial of GT90001 plus nivolumab in metastatic hepatocellular carcinoma is displayed, including its eligibility criteria, study design, outcomes, locations, and record dates.
    Difference
    53%
    Check dated 2026-11-08T06:26:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T04:55:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T06:52:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T06:34:21.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T08:31:22.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with limited HTML indicating an access restriction. The addition also includes a Home link and a revision note, reflecting a blocked access state rather than the intended study record.
    Difference
    19%
    Check dated 2026-09-20T03:18:16.000Z thumbnail image

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.